0
0.5
1
1.5
2+
Time to viral-
20%
Improvement
Relative Risk
Paxlovid for COVID-19 Shao et al. EARLY TREATMENT
Is early treatment with paxlovid beneficial for COVID-19?
Retrospective 131 patients in China (April - May 2022)
Study compares with lianhuaqingwen, results vs. placebo may differ
Faster viral clearance with paxlovid (p=0.00056)
c19early.org
Shao et al., medRxiv, July 2022
Favors paxlovid
Favors lianhuaqingwen